Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aravind Mittur

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Review of Clinical Pharmacology|November 26, 2011
Trazodone: properties and utility in multiple disordersAravind Mittur
European Journal of Drug Metabolism and Pharmacokinetics|January 7, 2018
A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and UrineAravind Mittur
Clinical Pharmacology in Drug Development|February 14, 2026
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 StudyAravind Mittur, Susan A VanMeter
Molecular Pharmacology|January 26, 2002
The thiol sensitivity of glutathione transport in sidedness-sorted basolateral liver plasma membrane and in Oatp1-expressing HeLa cell membraneAravind Mittur, Allan W Wolkoff, Neil Kaplowitz
Clinical Pharmacokinetics|February 26, 2017
Pharmacokinetics of Rytary<sup>®</sup>, An Extended-Release Capsule Formulation of Carbidopa-LevodopaAravind Mittur, Suneel Gupta, Nishit B Modi
Journal of Clinical Pharmacology|March 25, 2024
Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and NorfenfluramineAravind Mittur, Ryan Madanick, Melanie Langlois, et al.
Clinical Therapeutics|July 18, 2024
Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy AdultsAravind Mittur, Susan A VanMeter, Elmar Orujov, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2016
Pharmacokinetics, distribution, metabolism, and excretion of the dual reuptake inhibitor [(14)C]-nefopam in ratsJian Yu, Eric Solon, Helen Shen, et al.
Clinical Neuropharmacology|July 16, 2019
Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor FluctuationsNishit B Modi, Aravind Mittur, Phillip Dinh, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 23, 2016
Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteersMadhu Sanga, John Banach, Aaron Ledvina, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|November 26, 2011
Trazodone: properties and utility in multiple disordersAravind Mittur
European Journal of Drug Metabolism and Pharmacokinetics|January 7, 2018
A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and UrineAravind Mittur
Clinical Pharmacology in Drug Development|February 14, 2026
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 StudyAravind Mittur, Susan A VanMeter
Molecular Pharmacology|January 26, 2002
The thiol sensitivity of glutathione transport in sidedness-sorted basolateral liver plasma membrane and in Oatp1-expressing HeLa cell membraneAravind Mittur, Allan W Wolkoff, Neil Kaplowitz
Clinical Pharmacokinetics|February 26, 2017
Pharmacokinetics of Rytary<sup>®</sup>, An Extended-Release Capsule Formulation of Carbidopa-LevodopaAravind Mittur, Suneel Gupta, Nishit B Modi
Journal of Clinical Pharmacology|March 25, 2024
Effect of Hepatic Impairment on the Pharmacokinetics of Fenfluramine and NorfenfluramineAravind Mittur, Ryan Madanick, Melanie Langlois, et al.
Clinical Therapeutics|July 18, 2024
Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy AdultsAravind Mittur, Susan A VanMeter, Elmar Orujov, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2016
Pharmacokinetics, distribution, metabolism, and excretion of the dual reuptake inhibitor [(14)C]-nefopam in ratsJian Yu, Eric Solon, Helen Shen, et al.
Clinical Neuropharmacology|July 16, 2019
Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor FluctuationsNishit B Modi, Aravind Mittur, Phillip Dinh, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 23, 2016
Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteersMadhu Sanga, John Banach, Aaron Ledvina, et al.
Pageof 2